| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.082 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.096 | 0.09 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.1 | 0.05 |